Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Thought Leadership
Latest Report
JP Morgan 2022 Conference
Evaluate Vantage provided comprehensive coverage of the 40th Annual J.P. Morgan Health Care Conference, held virtually from 10 to 13 January. This article pack rounds up our key takeaways and data-driven insights. Access your complimentary copy now and delve into the most important news, breakthroughs and developments unveiled at the event.…
Report library
PD(L)anner - December 2021
In this special report, we provide you with the latest Evaluate Vantage update on clinical and regulatory developments in the PD-(L)1 inhibitor space. Among other issues,…
ASH 2022 Conference Round Up
This article pack, produced by Evaluate Vantage’s team of award-winning journalists, presents expert analysis and insights on data recently presented at the 63rd annual…
Infographic: Evaluate Vantage 2022 Preview
Leading up to the publication of the Evaluate Vantage 2022 Preview, we created this Infographic to provide a snapshot of the products and companies that are driving top…
Investor Interviews: Evaluate Vantage 2022 Preview
After a bruising 2021, biotech investors are hoping for a rebound. We interviewed investors and biopharma participants from across the sector, asking them to share their…
Evaluate Vantage 2022 Preview Report
Covid-19 will still be a front-page story in 2022, keeping the biopharma sector in the spotlight. The attention will bring some benefits, largely in the shape of broad…
